Expanded/​Activated Gamma Delta T-cell Infusion

Phase I Study of Ex Vivo Expanded/Activated Gamma Delta T-cell Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1
Enrollment
38 patients (estimated)
Sponsors
University of Kansas Cancer Center, University of Kansas Cancer Center
Collaborators
In8bio Inc.
Tags
Adoptive Cellular Therapy, T Cell, Post-Allogeneic Stem Cell Transplant
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1593
NCT Identifier
NCT03533816

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.